Targeted Genomic Sequencing via Selective Amplification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current genome sequencing technologies are economically unfeasible for de novo sequencing and struggle to accurately characterize 5-10% of the human genome, particularly regions with structural features resistant to characterization, such as heterochromatic gaps near centromeres and the HLA complex.

Innovation Solution

A method involving targeted coverage of selected genomic regions through selective amplification and barcoding, allowing for de novo sequence assembly and high-throughput re-sequencing of remaining regions with high accuracy, using techniques like PCR amplification and barcoding to achieve deep coverage and retain molecular context.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If de novo sequencing of the entire genome is performed, then complete genome assembly is achieved, but the cost becomes economically unfeasible

Engineering Contradiction:
Improvegenome assembly completenessVSAvoidsequencing cost
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The genome is divided into two categories: well-characterized regions and poorly characterized regions. The invention applies different sequencing strategies to each segment - targeted deep sequencing for poorly characterized regions and re-sequencing for well-characterized regions, making the overall process economically feasible while maintaining complete genome assembly

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention applies different sequencing depths and methods to different genomic regions based on their characterization status. Poorly characterized regions receive targeted deep sequencing (100x-5000x coverage) while well-characterized regions undergo standard re-sequencing, optimizing resource allocation and cost efficiency

Inventive Principle:
Principle #3Local quality

2Productivity

If standard sequencing technologies are used, then high throughput is achieved, but accuracy in characterizing structurally complex regions deteriorates

Engineering Contradiction:
Improvesequencing throughputVSAvoidstructural feature characterization accuracy
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The invention performs preliminary identification of poorly characterized genomic regions using reference genome comparison. This preliminary action enables targeted enrichment and deep sequencing of specific regions that require high accuracy, while maintaining high throughput for the remainder of the genome through standard re-sequencing methods

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The invention applies excessive sequencing depth (100x-5000x coverage) specifically to poorly characterized regions rather than uniformly across the entire genome. This partial application of excessive action ensures high accuracy for structurally complex regions while maintaining overall high throughput and cost efficiency

Inventive Principle:
Principle #16Partial or excessive action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables efficient and cost-effective de novo sequencing of poorly characterized regions while maintaining molecular context, providing sufficient sequence information for assembly and retaining high accuracy across the genome.

Implementation Method 1

amplifying selected portions of at least some of the individual nucleic acid molecules in the discrete partitions to form a population of amplicons

Methodology Applied
Scientific EffectPCR amplification:

Data Source

PatentUS11274343B2Methods and compositions for targeted nucleic acid sequence coverage
Publication Date: 2022.03.15 10X GENOMICS INC
  • US11274343B2 patent drawing
  • US11274343B2 patent drawing
  • US11274343B2 patent drawing

AI summary

The present invention is directed to methods, compositions and systems for analyzing sequence information from targeted regions of a genome. Such targeted regions may include regions of the genome that are poorly characterized, highly polymorphic, or divergent from reference genome sequences.